New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and treatment for patients of African ancestry.

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven effectiveness in extending survival.

Prostate cancer is one of the most common cancers among men in the United States. About one in eight men will be diagnosed with prostate cancer in their lifetime, according to the American Cancer Society. Dr. Edmund Folefac, from the Ohio State University ...

Former President Joe Biden, 82, completed a round of radiation therapy for aggressive prostate cancer. He received treatment at Penn Medicine Radiation Oncology in Philadelphia. The diagnosis followed his withdrawal from reelection last year and recent ...